Wells Fargo & Company Antares Pharma, Inc. Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
N/A
-151,406 Closed
0 $0
Q1 2022

May 16, 2022
SELL
N/A
-55,111 Reduced 26.69%
151,406 $621,000
Q4 2021

Feb 14, 2022
SELL
N/A
-456,910 Reduced 68.87%
206,517 $737,000
Q3 2021

Nov 15, 2021
BUY
N/A
112,719 Added 20.47%
663,427 $2.42 Million
Q2 2021

Aug 16, 2021
BUY
N/A
212,405 Added 62.79%
550,708 $2.4 Million
Q1 2021

May 13, 2021
SELL
N/A
-94,075 Reduced 21.76%
338,303 $1.39 Million
Q4 2020

Feb 09, 2021
BUY
N/A
49,974 Added 13.07%
432,378 $1.73 Million
Q3 2020

Nov 05, 2020
SELL
N/A
-15,019 Reduced 3.78%
382,404 $1.03 Million
Q2 2020

Aug 13, 2020
BUY
N/A
93,095 Added 30.59%
397,423 $1.09 Million
Q1 2020

May 14, 2020
BUY
N/A
304,328 New
304,328 $717,000

About Antares Pharma, Inc.

ATRS Quotes by TradingView
  • Ticker ATRS
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 170,042,000
  • Market Cap $951M
More about ATRS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email